The investigators wish to test a diagnostic risk score for autoimmune encephalitis in case of encephalitis, previously validated by two American teams, in a retrospective analysis, according to the clinical and paraclinical data available in our database of the Reference Centre for Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes of Professor Honnorat for patients with NMDAr, anti LGi1, anti CASPR2, anti GABAbr and anti GAD antibodies.
Study Type
OBSERVATIONAL
Enrollment
350
Compare the performance of the clinical prediction score of confirmed autoimmune encephalitis according to the type of antibody isolated from the CSF.
Centre de référence des syndromes neurologiques paranéoplasiques et encéphalites auto-immunes
Lyon, France
Validation of a diagnostic score for encephalitis to assess the risk of autoimmune origin.
Comorbidities assessed by the Charlson score
Time frame: At baseline
Symptoms in the acute phase
Time frame: At baseline
Mode of onset of disease
Time frame: At baseline
Results of lumbar puncture
Time frame: At baseline
Results of antineuronal antibodies in CSF
Time frame: At baseline
Results of antineuronal antibodies in serum
Time frame: At baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.